Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official (Orlando, FL, United States - February 1-2, 2018) - Research and Markets

Research and Markets
Posted on: 13 Nov 17

The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official" conference has been added to Research and Markets' offering.

The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times.

This two day workshop will provide you with an in-depth review of the content and format requirements of the CTD/eCTD. Hands-on activities will include organizing specific study reports and other documents into the CTD, using tools for the project management of the CTD preparation, and pre-publishing an eCTD.

Who Should Attend

  • Regulatory Affairs
  • Quality Assurance
  • Pharmacovigilance
  • Project Management
  • Regulatory Operations
  • Medical and Technical writers
  • Professionals preparing IND, DMFs, NDAs and other submissions
  • IT Professionals
  • Anyone responsible for providing content for the CTD

Agenda:

Day 01 (8:30 AM - 4:30 PM)

Lecture 1: Overview of the drug development program and source of relevant submission documents

Lecture 2: Discussion of the roles and responsibilities for CTD preparation

Lecture 3: Review of the CTD format requirements

Lecture 4: Discussion on the successful transition from other formats to the CTD

Lecture 5: Placement of content into the CTD format; including less obvious items

Lecture 6: Review of different requirements across regions (US, EU, Canada)

Lecture 7: Implementing tools for the project management of CTD preparation and publishing

Day 02 (8:30 AM - 4:30 PM)

Lecture 8: Technical requirements for an eCTD submission

Lecture 9: Document naming requirements

Lecture 10: Building the folder structure

Lecture 11: Internal document requirements for the eCTD

Lecture 12: Performing "pre-publishing" work for each document

Lecture 13: Tools for tracking and managing eCTD content

Lecture 14: Performing quality checks on the eCTD

Lecture 15: Updating content in the CTD and eCTD (amendments, supplements, variations, etc.)

For more information about this conference visit https://www.researchandmarkets.com/research/vvh9d4/ectd_submissions

View source version on businesswire.com: http://www.businesswire.com/news/home/20171113005570/en/

Business Wire
www.businesswire.com

Last updated on: 13/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.